Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases

被引:2
|
作者
Rivas-Macho, Ane [1 ]
Romeo, Maria V. [1 ,2 ]
Rackles, Elisabeth [3 ]
Olabarria, Garbine [1 ]
Falcon-Perez, Juan Manuel [3 ,4 ,5 ]
Berganza-Granda, Jesus [1 ]
Cortajarena, Aitziber L. [2 ,5 ]
Goni-de-Cerio, Felipe [1 ]
机构
[1] GAIKER Technol Ctr, Basque Res & Technol Alliance BRTA, Zamudio, Spain
[2] Ctr Cooperat Res Biomat CICbiomaGUNE, Basque Res & Technol Alliance BRTA, San Sebastian, Spain
[3] Ctr Cooperat Res Biosci CIC bioGUNE, Exosomes Lab, Basque Res & Technol Alliance BRTA, Bizkaia Technol Pk 801, Derio, Spain
[4] Ctr Invest Biomed Red enfermedades hepat & digest, Madrid, Spain
[5] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
关键词
Heat shock protein; cancer; infectious diseases; biomarker; diagnosis; MOLECULAR-MECHANISM; SERUM BIOMARKER; LUNG-CANCER; HSP90; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EXOSOMES; GRP94;
D O I
10.1080/14737159.2023.2246883
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
IntroductionThe heat shock protein 90 (Hsp90) is a protein involved in many different biological processes and especially in cell survival. Some of these functions require the participation of other biological molecules, so Hsp90 is a chaperone that takes part in many protein-protein interactions working as a critical signaling hub protein. As a member of the heat shock protein family, Hsp90 expression is regulated under certain environmental and/or stressful situations, therefore Hsp90 concentration can be monitored and linked to these effects.Areas coveredThis review discusses the Hsp90 expression in samples from individuals affected by different diseases (from infectious to cancer origin), and the biological consequences of these disorders, including the potential use of Hsp90 as a biomarker for the diagnosis of human diseases.Expert opinionThe potential of Hsp90 as a biomarker disease has been demonstrated in several studies in relation to infectious diseases and especially cancer. However, further research in this field is still needed, mainly to validate in statistically significant clinical studies that the detection of Hsp90 protein allows the diagnosis of some cancers at an early stage and also that it can act as a biomarker for monitoring the efficacy of their therapies.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 50 条
  • [41] Heat Shock Protein 90 Inhibitors in Oncology
    Ozgur, Aykut
    Tutar, Yusuf
    CURRENT PROTEOMICS, 2014, 11 (01) : 2 - 16
  • [42] The heat shock protein 90 of Leishmania donovani
    Wiesgigl, M
    Clos, J
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 190 (1-2) : 27 - 31
  • [43] Heat shock protein 90: a capacitor or a mutator?
    Sawarkar, Ritwick
    Paro, Renato
    JOURNAL OF BIOSCIENCES, 2010, 35 (02) : 163 - 165
  • [44] Heat shock protein 90 inhibition in the endothelium
    Barabutis, Nektarios
    FRONTIERS IN MEDICINE, 2023, 10
  • [45] Heat shock protein 90 antibodies in autism
    M Evers
    C Cunningham-Rundles
    E Hollander
    Molecular Psychiatry, 2002, 7 : S26 - S28
  • [46] Is heat shock protein 90 the cancer chaperone?
    Neckers, Len
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [47] Heat shock protein 90 antibodies in autism
    Evers, M
    Cunningham-Rundles, C
    Hollander, E
    MOLECULAR PSYCHIATRY, 2002, 7 (Suppl 2) : S26 - S28
  • [48] The heat shock protein 90 of Leishmania donovani
    Martina Wiesgigl
    Joachim Clos
    Medical Microbiology and Immunology, 2001, 190 : 27 - 31
  • [49] Heat shock protein 90: the cancer chaperone
    Neckers, Len
    JOURNAL OF BIOSCIENCES, 2007, 32 (03) : 517 - 530
  • [50] Heat shock protein 90: a capacitor or a mutator?
    Ritwick Sawarkar
    Renato Paro
    Journal of Biosciences, 2010, 35 : 163 - 165